---
figid: PMC10741086__biomedicines-11-03142-g002
pmcid: PMC10741086
image_filename: PMC10741086__biomedicines-11-03142-g002.jpg
figure_link: /pmc/articles/PMC10741086/figure/F2/
number: Figure 2
figure_title: Main metabolic pathway involved on the activation, proliferation, and
  differentiation of CD4+ T cells, and targets for metabolic modulators.
caption: Main metabolic pathway involved on the activation, proliferation, and differentiation
  of CD4+ T cells, and targets for metabolic modulators. AMPK, AMP-activated protein
  kinase; BPTES, bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide; CoQ,
  coenzyme Q10; 2 DG, 2-deoxy-D-glucose; Gls1, Glutaminase 1; HK, hexokinase; PDH,
  Pyruvate dehydrogenase; PDK, Pyruvate dehydrogenase kinase; PFK1, Phosphofructokinase-1;
  PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase; 3 PO, 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one;
  TCA cycle, tricarboxylic acid cycle; mTORC1, Mammalian target of rapamycin complex
  1
article_title: Metabolic Modulators in Cardiovascular Complications of Systemic Lupus
  Erythematosus
citation: Sofía Miñano, et al. Biomedicines. 2023 Dec;11(12).
year: '2023'
pub_date: 2023-12-
epub_date: '2023-11-25'
doi: 10.3390/biomedicines11123142
journal_title: Biomedicines
journa_nlm_ta: Biomedicines
publisher_name: MDPI
keywords:
- systemic lupus erythematosus
- endothelial dysfunction
- hypertension
- immunometabolism
---
